Missing/wrong data?
Log in to edit
Evaluation of Two Dosing Regimens for Nivolumab in Combination With Ipilimumab in Patients With Advanced Melanoma: Results From the Phase IIIb/IV CheckMate 511 Trial
scientific article published on 27 February 2019
Author/s
author: Nicolas Meyer, Ivan Marquez-Rodas, Piotr Rutkowski, Inge Marie Svane, Paolo Antonio Ascierto, Alexander M Menzies, Dirk Schadendorf
Work details
Publication date
February 27, 2019
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.